Gilead Sciences, Inc. is a research-based biopharmaceutical company. Its filings show it lobbies mainly on corporate and international tax matters, including issues tied to the Internal Revenue Code and specific legislation (P.L. 119-21). It hired a tax-focused lobbying firm for these services and reported about $300,000 in lobbying since 2026 filings began.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
CHRISTOPHER JAVENS
The latest disclosures for this client.
CAPITOL TAX PARTNERS, LLP
Q2CAPITOL TAX PARTNERS, LLP
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
CAPITOL TAX PARTNERS, LLP
LAWRENCE WILLCOX
CAPITOL TAX PARTNERS, LLP
SARAH ELIZABETH SHIVE
CAPITOL TAX PARTNERS, LLP
ms KATHERINE SCOLLARD MONGE
CAPITOL TAX PARTNERS, LLP
CAPITOL TAX PARTNERS, LLP
4ACAPITOL TAX PARTNERS, LLP
Q4CAPITOL TAX PARTNERS, LLP
Q3CAPITOL TAX PARTNERS, LLP
Q2CAPITOL TAX PARTNERS, LLP
Q1